TT&A advised Jefferies India Private Limited which acted as the broker in connection with the secondary sale of up to 3,700,000 equity shares of face value of INR 1 each in Ajanta Pharma Limited by Ravi Agrawal Trust, one of the promoters of Ajanta Pharma Limited amounting to approximately INR 10,240 million (approx. USD 100 million). The deal was undertaken on the screen-based trading platform of the BSE Limited and the NSE of India Limited.
TT&A Team: Abhinav Kumar – Partner and Indira Satish – Senior Associate
By browsing this website you agree that you are, of your own accord, seeking further information regarding TT&A. No part of this website should be construed as an advertisement of or solicitation for our professional services. No information provided on this shall be construed as legal advice.